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We compared the follow-up data on loop diuretic use and renal
function, as assessed by serum creatinine levels, and the estimated
glomerular ﬁltration rate (eGFR), of two groups of consecutive
ambulatory HF patients: 1) the clinically-guided group, in which
management was clinically driven based on the institutional protocol
of the HF Unit of the Cardiovascular and Thoracic Department of Pisa
(standard of care) and 2) the echo and B-type natriuretic peptide
(BNP) guided group (patients conforming to the protocol of the Net-
work Labs Ultrasound (NEBULA) in HF Study Group: Pisa, Perugia,
Pavia; Verona, Auckland, and Veruno), inwhich therapy was delivered
according to the serial assessment of BNP and echocardiography.
Patients whose follow-up was based on standard of care had a sig-
niﬁcant higher prevalence of worsening renal function, that was likely
related to higher diuretic dosages, whilst, a better management of
renal function was observed in the echo-BNP-guided group. The datavier Inc. This is an open access article under the CC BY license
/j.ijcard.2016.09.034
ini).
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F.L. Dini et al. / Data in Brief 9 (2016) 1074–1076 1075is related to “Echo and natriuretic peptide guided therapy improves
outcome and reduces worsening renal function in systolic heart fail-
ure: An observational study of 1137 outpatients” (A. Simioniuc, E.
Carluccio, S. Ghio, A. Rossi, P. Biagioli, G. Reboldi, G.G. Galeotti, F. Lu, C.
Zara, G. Whalley, P.G. Temporelli, F.L. Dini, 2016; K.J. Harjai, H.K. Din-
shaw, E. Nunez, M. Shah, H. Thompson, T. Turgut, H.O. Ventura, 1999;
A. Ahmed, A. Husain, T.E. Love, G. Gambassi, L.J. Dell'Italia, G.S. Francis,
M. Gheorghiade, R.M. Allman, S. Meleth, R.C. Bourge, 2006) [1–3].
& 2016 The Authors. Published by Elsevier Inc. This is an open access
article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations Tableubject area Medicine
ore speciﬁc subject
areaCardiologyype of data Tables
ow data was acquired Echocardiography, biochemical testing of serum BNP and creatinine
ata format Analysed
xperimental factors Consecutive patients with chronic heart failure with reduced ejection frac-
tion (EF)
xperimental features Retrospective, multicentre, observational study
ata source location Pisa, Perugia, Pavia; Verona, Auckland, Veruno
ata accessibility Data is with this articleD
Value of the data
 Echo and BNP guided HF care can provide a tailored approach to the diuretic treatment [1].
 This strategy can prevent worsening renal function in chronic HF and, thus, may impact patients’
survival [2,3].1. Data
Transthoracic two-dimensional and Doppler echocardiographic examination was carried out with
commercial equipments with 2nd-harmonic imaging. BNP concentrations were processed by Alere
Triage BNP Test for Beckman Coulter Immunoassay Systems (Alere San Diego Inc., San Diego, CA,
USA), a two-site immunoenzymatic (sandwich) quantitative assay. The eGFR was calculated from the
simpliﬁed formula derived from the Modiﬁcation of Diet in Renal Disease study. Supplementary
Table 1 shows the characteristics of the study groups. Supplementary Table 2 describes the data on
diuretic use (furosemide dose) and the changes in renal function [1].2. Experimental design, materials and methods
This was a retrospective, multicenter, observational study that involved 1137 consecutive out-
patients (total cohort). In a group of 570 patients with HF (mean ejection fraction [EF]¼30%), man-
agement was guided according to the presence of echo signs of elevated left ventricular ﬁlling
pressure and serum BNP levels, while in the other (n¼567, mean EF¼33%), management was based
on clinical judgment. In the latter group, echocardiography was repeated only in the case of changes
in clinical status.
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